Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan

BACKGROUND: Accelerated tumor growth during immunotherapy in pre-existing measurable lesions, hyperprogressive disease (HPD), has been reported. However, progression of non-measurable lesions and new lesions are frequently observed in patients with advanced gastric cancer (AGC). METHODS: This retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoki, Masahiko, Kadowaki, Shigenori, Takahashi, Naoki, Suzuki, Takeshi, Oshima, Kotoe, Ando, Takayuki, Yamamoto, Yoshiyuki, Kawakami, Kentaro, Kito, Yosuke, Matsumoto, Toshihiko, Shimozaki, Keitaro, Miyazaki, Yasuhiro, Yamaguchi, Toshifumi, Nagase, Michitaka, Tamura, Takao, Amanuma, Yusuke, Esaki, Taito, Miura, Yuji, Akiyoshi, Kohei, Baba, Eishi, Makiyama, Akitaka, Negoro, Yuji, Nakashima, Koji, Sugimoto, Naotoshi, Nagashima, Kengo, Shoji, Hirokazu, Boku, Narikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813080/
https://www.ncbi.nlm.nih.gov/pubmed/36316527
http://dx.doi.org/10.1007/s10120-022-01349-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813080/
https://www.ncbi.nlm.nih.gov/pubmed/36316527
http://dx.doi.org/10.1007/s10120-022-01349-y

Ejemplares similares